← Browse by Condition
Medical Condition
cystic fibrosis
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1
ClinicalMetric tracks all active clinical trials for cystic fibrosis sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — cystic fibrosis Clinical Trials
How many clinical trials are currently recruiting for cystic fibrosis?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for cystic fibrosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cystic fibrosis?
cystic fibrosis research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cystic fibrosis clinical trial?
Eligibility criteria for cystic fibrosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05766774
Recruiting
FEED-Cystic Fibrosis (FEED-CF)
Enrollment
60 pts
Location
United States
Sponsor
Emory University
NCT02965326
Recruiting
Surrogate Markers of Response to New Therapies in Cystic Fibrosis Patients
Enrollment
75 pts
Location
France
Sponsor
Hôpital Necker-Enfants Malades
NCT04509050
Recruiting
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
Enrollment
210 pts
Location
United States
Sponsor
Sonya Heltshe
NCT05982795
Recruiting
Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome
Enrollment
30 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce...
NCT06191640
Recruiting
Sinus Disease in Young Children With Cystic Fibrosis
Enrollment
80 pts
Location
United States
Sponsor
University of California, Los ...
NCT05099939
Recruiting
Identification of Dysglycemia With Continuous Glucose Monitoring to Assess Clinical Evolution in Cystic Fibrosis
Enrollment
121 pts
Location
Canada, France
Sponsor
Institut de Recherches Cliniqu...
NCT04793867
Recruiting
Regional Phenotyping of CF and Non-CF Bronchiectasis
Enrollment
100 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
NCT06313827
Recruiting
e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population
Enrollment
60 pts
Location
Spain
Sponsor
University of Valencia
NCT05802264 Phase 1
Recruiting
Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis
Enrollment
108 pts
Location
Australia, New Zeala...
Sponsor
Cystetic Medicines, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology